Informed choices in anti-inflammatory drug therapy: why patient risk matters.
Scheiman
James M
JM
From the *Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; †Consortium for Health Outcomes, Innovation, and Cost-Effectiveness Studies (CHOICES), Ann Arbor, MI; and ‡Division of General Medicine, Department of Internal Medicine, University of Michigan University of Michigan School of Medicine, Ann Arbor, MI.
Fendrick
A Mark
AM